CRIS

Permanent URI for this communityhttps://scripta.up.edu.mx/handle/20.500.12552/1

Browse

Settings

Access type: UnknownSubject: search.filters.subject.De-escalating

Search Results

Now showing 1 - 1 of 1
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Item type:Publication,
    De-escalating treatment indications for patients who achieve metabolic goals
    (Elsevier, 2024)
    García-Ulloa, Ana Cristina
    ;
    Jaime-Casas, Salvador
    ;
    Rosado-Lozoya, Johanna S.
    ;
    Serrano-Pérez, Nancy H.
    ;
    Hernández-Juárez, Diana
    Introduction: Robust evidence exists regarding initiation, intensification or modification of treatments. Recommendations to de-escalate therapy are lacking, specifically in diabetes. A successful treatment de-intensification reduces overtreatment, polypharmacy, and risk of adverse effects. Objective: To encompass current recommendations for deprescribing common drugs and create a consensus among health professionals. Methods: We reviewed four databases for deprescribing approaches published between 2010 and 2022. Articles were divided into different groups of drugs (for uric-acid, hypoglycemic, lipid-lowering, and psychotropic drugs).©Elsevier
      16  1